Galcanezumab for Migraine
Phase-Based Progress Estimates
Effectiveness
Safety
Migraine+2 More
Galcanezumab - DrugEligibility
18+
All Sexes
What conditions do you have?
Select
Eligibility
18+
All Sexes
What conditions do you have?
Select
Study Summary
This trial will compare the effectiveness of two drugs for preventing migraines. It will last for six months.
Eligible Conditions
- Migraine
- Episodic Migraine
Treatment Effectiveness
Effectiveness Progress
This is further along than 93% of similar trials
Study Objectives
1 Primary · 10 Secondary · Reporting Duration: Month 1 through Month 3
Baseline, 3 Months
Change from Baseline in Emotional Function (EF) Domain Score of Migraine-Specific Quality of Life Questionnaire Version 2.1 (MSQ v2.1)
Change from Baseline in MIDAS (Migraine Disability Assessment) Total Score
Change from Baseline in Migraine-Specific Quality of Life Questionnaire Version 2.1 (MSQ v2.1) Total Score
Change from baseline in Role Function-Preventive (RF-P) Domain Score of Migraine-Specific Quality of Life Questionnaire Version 2.1 (MSQ v2.1)
Mean Change from Baseline in the Number of Monthly Migraine Headache Days
Mean Change from Baseline in the Role Function-Restrictive (RF-R) Domain Score of the Migraine-Specific Quality of Life Questionnaire Version 2.1 (MSQ v2.1)
Month 3
Overall Mean Change from Baseline in the Number of Monthly Migraine Headache Days
Overall Mean Change from Baseline in the Number of Monthly Migraine Headache Days Requiring Medication for the Acute Treatment of Migraine or Headache
Month 3
Mean Monthly Percentage of Participants with a 100% Response Rate
Mean Monthly Percentage of Participants with a 50% Response Rate
Mean Monthly Percentage of Participants with a 75% Response Rate
Trial Safety
Safety Progress
This is further along than 85% of similar trials
Side Effects for
240 mg Galcanezumab SC
6%Abdominal pain upper
3%Constipation
Trial Design
2 Treatment Groups
Rimegepant
1 of 2
Galcanezumab
1 of 2
Active Control
Experimental Treatment
575 Total Participants · 2 Treatment Groups
Primary Treatment: Galcanezumab · Has Placebo Group · Phase 4
GalcanezumabExperimental Group · 2 Interventions: Placebo, Galcanezumab · Intervention Types: Drug, Drug
RimegepantActiveComparator Group · 2 Interventions: Placebo, Rimegepant · Intervention Types: Drug, Drug
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Placebo
1995
Completed Phase 3
~2670
Galcanezumab
FDA approved
Trial Logistics
Trial Timeline
Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: month 1 through month 3
Who is running the clinical trial?
Eli Lilly and CompanyLead Sponsor
2,453 Previous Clinical Trials
3,120,150 Total Patients Enrolled
25 Trials studying Migraine
9,993 Patients Enrolled for Migraine
Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST)Study DirectorEli Lilly and Company
1,250 Previous Clinical Trials
366,978 Total Patients Enrolled
20 Trials studying Migraine
7,150 Patients Enrolled for Migraine
Eligibility Criteria
Age 18+ · All Participants · 1 Total Inclusion Criteria
Mark “yes” if the following statements are true for you:About The Reviewer
Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.
Who else is applying?
What state do they live in?
| North Carolina | 33.3% |
| Texas | 33.3% |
| Delaware | 33.3% |
How old are they?
| 18 - 65 | 100.0% |
What site did they apply to?
| FutureSearch Trials of Neurology | 50.0% |
| Alliance for Multispecialty Research, LLC - AMR Norfolk | 50.0% |
What portion of applicants met pre-screening criteria?
| Met criteria | 100.0% |
Popular Clinical Trials
Top Clinical Trials in Cities
Relevant Clinical Trials
Unbiased Results
We believe in providing patients with all the options.Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.Back to top
Conditions
Cancer Related
Treatments